🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06643429
Active, not recruiting Observational

Impact of Environmental Factors and Metabolomics on Colorectal Cancer.

NCT06643429 · tracked via the Priya Life Science China tracker
Sponsor
Dong Peng
Phase
Observational
Started
2024-10-01
Last updated
2024-10-16

Condition(s) studied

Colorectal CancerMetabolic Disease

Investigational drug(s) / intervention(s)

colorectal cancercolorectal neoplasm

colorectal cancer: Patients diagnosed with colorectal cancer by pathological biopsy.

colorectal neoplasm: Patients diagnosed with colorectal adenoma confirmed by colonoscopy.

Study summary

Colorectal cancer is one of the malignant tumours with high morbidity and mortality worldwide, posing a serious threat to human health. In recent years, the incidence of colorectal cancer has been on the rise with changes in lifestyle and dietary habits. Although some progress has been made in treatments such as surgery, chemotherapy and radiotherapy, however, the early diagnosis, prognosis assessment and personalised treatment of colorectal cancer still face great challenges. Therefore, it is of great academic value and practical significance to deeply explore the influencing factors of colorectal cancer occurrence, development and its prognosis, especially the research on environmental factors and metabolomics.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: 1. Healthy control group: * age ≥18 years old; * no history of malignant tumour; * willing to participate in this study and sign the informed consent form; * complete basic data. 2. Gastric cancer group: * age ≥18 years old; * patients diagnosed with gastric cancer by pathological biopsy before operation; * no chemotherapy, radiotherapy, targeted and immunotherapy before enrolment; * willing to participate in this study and sign the informed consent; complete clinical data. Exclusion criteria: * patients with primary malignant tumours other than gastric cancer; * patients with serious cardiopulmonary insufficiency and other systemic diseases that affect the choice of treatment plan; * patients who are not suitable for enrolment as assessed by the investigator.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
the First Affiliated Hospital of Chongqing Medical University Chongqing Chongqing Municipality

More Dong Peng trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06643429 on ClinicalTrials.gov ↗ ← All trials in China